Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

CYTKCYTK
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in CYTOKINETICS INC

NORTHERN TRUST CORP holds 1.6M shares of CYTK (CYTOKINETICS INC), worth $140.3M as of 2026-Q2. The position was increased (+14.3% shares). CYTK represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$140.3M

Current Shares

1.6M

Total Value Change

+$70.1M

Total Shares Change

+317,691

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+14.3%
$140.3M0.0%$85.19
34
2026-Q1
Increased
1.4M
+4.4%
$95M0.0%$65.91
31
2025-Q4
Decreased
1.4M
-1.9%
$87.7M0.0%$63.54
0
2025-Q3
Increased
1.4M
+2.0%
$77.3M0.0%$54.96
30
2025-Q2
Decreased
1.4M
-4.7%
$45.6M0.0%$33.04
0
2025-Q1
Decreased
1.4M
-1.6%
$58.2M0.0%$40.19
0
2024-Q4
Increased
1.5M
+10.7%
$69.2M0.0%$47.04
33
2024-Q3
Increased
1.3M
+3.6%
$70.2M0.0%$52.80
31

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used